Company intelligence / Profile preview

Guangzhou Baiyunshan Chenliji Pharmaceutical Factory

Guangzhou, Guangdong, China

Ownership: Private
Employees: ~1300
Development stage: Other

Overview

Guangzhou Baiyunshan Chenliji Pharmaceutical Factory, as part of Baiyunshan and Guangzhou Pharmaceutical Holdings, produces over 300 products including antibiotics (approved), cardiovascular, and traditional Chinese medicine, with several generic and innovative drugs in commercial use and late-stage development. Notable products include generic sildenafil (JinGe), memantine, and cephalosporins.

Therapeutic areas: RheumatologyMen's HealthInfectious DiseasesOncologyNeurology
Modalities: Small moleculeHerbal medicine
Industry: Biotech

Drug pipeline

1 asset

Qianjin Baoyun Pills

Unknown

Partnerships

Sun Yat-Sen University, College of PharmacyPeking University

Beyond the preview

Go deeper on Guangzhou Baiyunshan Chenliji Pharmaceutical Factory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Baiyunshan Chenliji Pharmaceutical Factory.

Explore the full profile